HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
12 04 2021
Historique:
received: 14 07 2020
accepted: 11 03 2021
revised: 21 02 2021
entrez: 13 4 2021
pubmed: 14 4 2021
medline: 29 6 2021
Statut: epublish

Résumé

The atypical antipsychotic clozapine is the only effective medication for treatment-resistant schizophrenia. However, it can also induce serious adverse drug reactions, including agranulocytosis and neutropenia. The mechanism by which it does so is largely unknown, but there is evidence for contributing genetic factors. Several studies identified HLA-DQB1 variants and especially a polymorphism located in HLA-DQB1 (6672G>C, rs113332494) as associated with clozapine-induced agranulocytosis and neutropenia. We analysed the risk allele distribution of SNP rs113332494 in a sample of 1396 controls and 178 neutropenia cases of which 60 developed agranulocytosis. Absolute neutrophil counts of 500/mm

Identifiants

pubmed: 33846298
doi: 10.1038/s41398-021-01322-w
pii: 10.1038/s41398-021-01322-w
pmc: PMC8042025
doi:

Substances chimiques

Antipsychotic Agents 0
HLA-DQ beta-Chains 0
HLA-DQB1 antigen 0
Clozapine J60AR2IKIC

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

214

Subventions

Organisme : Medical Research Council
ID : G0801418
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L006758/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)
ID : 279227

Références

Genetics. 2014 Mar;196(3):625-42
pubmed: 24388880
CNS Drugs. 1997 Feb;7(2):139-58
pubmed: 23338132
Nat Genet. 2012 Jul 22;44(8):955-9
pubmed: 22820512
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Acta Psychiatr Scand. 2018 Aug;138(2):101-109
pubmed: 29786829
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Hum Mol Genet. 2012 Oct 15;21(R1):R58-65
pubmed: 22907657
Int J Neuropsychopharmacol. 2012 Oct;15(9):1351-71
pubmed: 22339930
Br J Psychiatry. 2016 Nov;209(5):385-392
pubmed: 27388573
Mol Psychiatry. 2019 Mar;24(3):328-337
pubmed: 30647433
Clin Schizophr Relat Psychoses. 2012 Oct;6(3):134-44
pubmed: 23006238
J Clin Psychopharmacol. 2005 Jun;25(3):276-7
pubmed: 15876910
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Curr Med Res Opin. 1997;14(1):1-20
pubmed: 9524789
Arch Gen Psychiatry. 1988 Sep;45(9):789-96
pubmed: 3046553
Pharmacogenomics J. 2017 Oct;17(5):471-478
pubmed: 27168101
Pharmacogenomics J. 2007 Oct;7(5):325-32
pubmed: 17001352
Lancet. 1975 Sep 27;2(7935):611
pubmed: 51442
G3 (Bethesda). 2011 Nov;1(6):457-70
pubmed: 22384356
Mol Psychiatry. 2017 Oct;22(10):1502-1508
pubmed: 27400856
Br J Psychiatry. 2000 Jul;177:88
pubmed: 10945101
Pharmacogenomics J. 2015 Oct;15(5):461-6
pubmed: 25732907
Clin Neurol Neurosurg. 2015 Mar;130:55-60
pubmed: 25577161
Clin Psychopharmacol Neurosci. 2013 Dec;11(3):168-9
pubmed: 24465255
Heredity (Edinb). 2013 Aug;111(2):131-8
pubmed: 23715014
Pharmacogenetics. 2001 Mar;11(2):135-41
pubmed: 11266078
Arch Gen Psychiatry. 1990 Oct;47(10):945-8
pubmed: 2222133
J Clin Psychiatry. 2011 Apr;72(4):458-63
pubmed: 20868635
Nat Commun. 2018 Aug 14;9(1):3258
pubmed: 30108219
Dialogues Clin Neurosci. 2014 Dec;16(4):555-66
pubmed: 25733959
Drug Saf. 1992;7 Suppl 1:7-9
pubmed: 1503679
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Stat Comput. 2011 Jan 4;21(2):261-273
pubmed: 21359052
J Lab Clin Med. 1999 Jan;133(1):15-22
pubmed: 10385477
Bioinformatics. 2015 Apr 15;31(8):1334-6
pubmed: 25431330
Genome Biol. 2011;12(5):223
pubmed: 21635713
Nat Commun. 2014 Sep 04;5:4757
pubmed: 25187353
Blood. 1995 Aug 1;86(3):1177-83
pubmed: 7620171

Auteurs

Bettina Konte (B)

Department of Psychiatry, Psychotherapy and Psychosomatics, Martin-Luther-University Halle-Wittenberg, Halle, Germany. bettina.konte@uk-halle.de.

James T R Walters (JTR)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.

Dan Rujescu (D)

Department of Psychiatry, Psychotherapy and Psychosomatics, Martin-Luther-University Halle-Wittenberg, Halle, Germany.

Sophie E Legge (SE)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.

Antonio F Pardiñas (AF)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.

Dan Cohen (D)

Department of Severe Mental Illness, Mental Health Care Organization North-Holland North, Heerhugowaard, The Netherlands.

Munir Pirmohamed (M)

Department of Pharmacology and Therapeutics, The University of Liverpool, Liverpool, England.

Jari Tiihonen (J)

Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.
Department of Clinical Neuroscience, Karolinska Institutet, and Center for Psychiatry Research, Stockholm City Council, Stockholm, Sweden.

Annette M Hartmann (AM)

Department of Psychiatry, Psychotherapy and Psychosomatics, Martin-Luther-University Halle-Wittenberg, Halle, Germany.

Jan P Bogers (JP)

Mental Health Services Rivierduinen, Oegstgeest, The Netherlands.

Jan van der Weide (J)

Department of Clinical Chemistry, St Jansdal Hospital, Harderwijk, The Netherlands.
Psychiatric Hospital GGz Centraal, Dependance Meerkanten, Ermelo, The Netherlands.

Karen van der Weide (K)

Department of Clinical Chemistry, St Jansdal Hospital, Harderwijk, The Netherlands.

Anu Putkonen (A)

Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.

Eila Repo-Tiihonen (E)

Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.

Tero Hallikainen (T)

Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.

Ed Silva (E)

Department of Pharmacology and Therapeutics, The University of Liverpool, Liverpool, England.

Oddur Ingimarsson (O)

Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavík, Iceland.
Landspitali University Hospital, Mental Health Services, Hringbraut, 101 Reykjavik, Iceland.

Engilbert Sigurdsson (E)

Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavík, Iceland.
Landspitali University Hospital, Mental Health Services, Hringbraut, 101 Reykjavik, Iceland.

James L Kennedy (JL)

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, M5T 1R8, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, M5T 1R8, Canada.
Institute of Medical Science, University of Toronto, Toronto, ON, M5S 1A8, Canada.

Patrick F Sullivan (PF)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, SE-17177, Sweden.
Department of Genetics, University of North Carolina, Chapel Hill, NC, 27599-7264, USA.
Department of Psychiatry, University of North Carolina, Chapel Hill, NC, 27599-7160, USA.

Marcella Rietschel (M)

Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Gerome Breen (G)

King's College London, London, UK.

Hreinn Stefansson (H)

deCODE Genetics/Amgen, Reykjavik, Iceland.

Kari Stefansson (K)

deCODE Genetics/Amgen, Reykjavik, Iceland.

David A Collier (DA)

SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Eli Lilly and Company, Bracknell, UK.

Michael C O'Donovan (MC)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.

Ina Giegling (I)

Department of Psychiatry, Psychotherapy and Psychosomatics, Martin-Luther-University Halle-Wittenberg, Halle, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH